The Senate health-care bill would give the wealthy the biggest tax break in over a decade, according to an analysis. » Read More
By: Dylan Matthews
Here's one idea for universal coverage that doesn't require sudden massive tax increases, says Dylan Matthews. » Read More
By: Bertha Coombs
The large for-profit insurers and hospitals will find ways to grow, whether or not the GOP's health-reform bill is passed this summer. » Read More
Niraparib was shown to extend the time elapsed between treatment of ovarian cancer and tumor progression.
Two vaccines for Zika protected against two common strains of the virus in mice, and will enter human trials soon.
Stifel Nicolaus started coverage on Cigna with a buy rating and a $169 target on shares, based on the current Anthem deal value.
The research could lead to the development of new medical sensors that can warn patients about potential symptoms.
The drug, a treatment option for people with Lennox-Gastaut syndrome, has been shown to reduce the number of monthly seizures in some patients.
Legendary has won the rights to "Bad Blood," a film about Theranos, according to The Hollywood Reporter.
Health regulators are proposing to make some Medicare drug payments based on how well those medications work for patients.
A common way of using smartphones fooled two women into thinking they were going blind.
Biotech stocks rallied after a government report said that Medicare cost-cutting measures will not be triggered this year.
Shares of Actuant plummeted more than 7 percent after the company released its fiscal third-quarter earnings.
U.S. House of Representatives Speaker Paul Ryan unveiled a Republican agenda that would repeal Obamacare but keep some of its more popular provisions.
Puberty may be arriving earlier thanks to chemicals, obesity, and other factors, but some say the talk is overblown.
The targets include those who paid the Obamacare penalty or who claimed an exemption to having health coverage.
Opko Health rose more than 5 percent after the U.S. Food and Drug Administration approved the drug Rayaldee.
Big employers will see health costs grow in line with trends, but there's a shift in what's driving spending, PwC's Health Research Institute says.
Emergent BioSolutions moved closer to FDA approval for a large-scale facility for making BioThrax, a vaccine for protection against anthrax.
The jury remains out on whether the slowdown in health spending is due to Obamacare or the overall economy.
The zika virus could already have a foothold in the southern United States, and public health officials are unprepared for it.
Google wants to make it easier for users to find answers to their symptom-related questions with medical information from doctors.
The rapid increase in Zika virus infections in Puerto Rico could put thousands of pregnant women at risk for potential infection.
Get the best of CNBC in your inbox